Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Psychometric evaluation of the near activity visual questionnaire presbyopia (NAVQ-P) and additional patient-reported outcome items

J. Sims, B. Sloesen, S. Bentley, C. Naujoks, R. Arbuckle, S. Chiva-Razavi, B. Pascoe, J. Stochl, A. Findley, P. O'Brien, JS. Wolffsohn

. 2024 ; 8 (1) : 41. [pub] 20240409

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24014347

Grantová podpora
Novartis Pharma Novartis Pharma

BACKGROUND: The Near Visual Acuity Questionnaire Presbyopia (NAVQ-P) is a patient-reported outcome (PRO) measure that was developed in a phakic presbyopia population to assess near vision function impacts. The study refined and explored the psychometric properties and score interpretability of the NAVQ-P and additional PRO items assessing near vision correction independence (NVCI), near vision satisfaction (NVS), and near vision correction preference (NVCP). METHODS: This was a psychometric validation study conducted using PRO data collected as part of a Phase IIb clinical trial (CUN8R44 A2202) consisting of 235 randomized adults with presbyopia from the US, Japan, Australia, and Canada. Data collected at baseline, week 2, and months 1, 2, and 3 during the 3-month trial treatment period were included in the analyses to assess item (question) properties, NAVQ-P dimensionality and scoring, reliability, validity, and score interpretation. RESULTS: Item responses were distributed across the full response scale for most NAVQ-P and additional PRO items. Confirmatory factor analysis supported the pre-defined unidimensional structure and calculation of a NAVQ-P total score as a measure of near vision function. Item deletion informed by item response distributions, dimensionality analyses, item response theory, and previous qualitative findings, including clinical input, supported retention of 14 NAVQ-P items. The 14-item NAVQ-P total score had excellent internal consistency (α = 0.979) and high test-retest reliability (Intraclass Correlation Coefficients > = 0.898). There was good evidence of construct-related validity for all PROs supported by strong correlations with concurrent measures. Excellent results for known-groups validity and ability to detect change analyses were also demonstrated. Anchor-based and distribution-based methods supported interpretation of scores through generation of group-level and within-individual estimates of meaningful change thresholds. A meaningful within-patient change in the range of 8-15-point improvement on the NAVQ-P total score (score range 0-42) was recommended, including a more specific responder definition of 10-point improvement. CONCLUSIONS: The NAVQ-P, NVCI, and NVS are valid and reliable instruments which have the ability to detect change over time. Findings strongly support the use of these measures as outcome assessments in clinical/research studies and in clinical practice in the presbyopia population.

000      
00000naa a2200000 a 4500
001      
bmc24014347
003      
CZ-PrNML
005      
20240905134423.0
007      
ta
008      
240725s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s41687-024-00717-9 $2 doi
035    __
$a (PubMed)38592339
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Sims, Joel $u Adelphi Values, Patient-Centered Outcomes, Bollington, UK. joel.sims@adelphivalues.com $1 https://orcid.org/0000000304742186
245    10
$a Psychometric evaluation of the near activity visual questionnaire presbyopia (NAVQ-P) and additional patient-reported outcome items / $c J. Sims, B. Sloesen, S. Bentley, C. Naujoks, R. Arbuckle, S. Chiva-Razavi, B. Pascoe, J. Stochl, A. Findley, P. O'Brien, JS. Wolffsohn
520    9_
$a BACKGROUND: The Near Visual Acuity Questionnaire Presbyopia (NAVQ-P) is a patient-reported outcome (PRO) measure that was developed in a phakic presbyopia population to assess near vision function impacts. The study refined and explored the psychometric properties and score interpretability of the NAVQ-P and additional PRO items assessing near vision correction independence (NVCI), near vision satisfaction (NVS), and near vision correction preference (NVCP). METHODS: This was a psychometric validation study conducted using PRO data collected as part of a Phase IIb clinical trial (CUN8R44 A2202) consisting of 235 randomized adults with presbyopia from the US, Japan, Australia, and Canada. Data collected at baseline, week 2, and months 1, 2, and 3 during the 3-month trial treatment period were included in the analyses to assess item (question) properties, NAVQ-P dimensionality and scoring, reliability, validity, and score interpretation. RESULTS: Item responses were distributed across the full response scale for most NAVQ-P and additional PRO items. Confirmatory factor analysis supported the pre-defined unidimensional structure and calculation of a NAVQ-P total score as a measure of near vision function. Item deletion informed by item response distributions, dimensionality analyses, item response theory, and previous qualitative findings, including clinical input, supported retention of 14 NAVQ-P items. The 14-item NAVQ-P total score had excellent internal consistency (α = 0.979) and high test-retest reliability (Intraclass Correlation Coefficients > = 0.898). There was good evidence of construct-related validity for all PROs supported by strong correlations with concurrent measures. Excellent results for known-groups validity and ability to detect change analyses were also demonstrated. Anchor-based and distribution-based methods supported interpretation of scores through generation of group-level and within-individual estimates of meaningful change thresholds. A meaningful within-patient change in the range of 8-15-point improvement on the NAVQ-P total score (score range 0-42) was recommended, including a more specific responder definition of 10-point improvement. CONCLUSIONS: The NAVQ-P, NVCI, and NVS are valid and reliable instruments which have the ability to detect change over time. Findings strongly support the use of these measures as outcome assessments in clinical/research studies and in clinical practice in the presbyopia population.
650    _2
$a dospělí $7 D000328
650    _2
$a lidé $7 D006801
650    12
$a myopie $7 D009216
650    _2
$a hodnocení výsledků péče pacientem $7 D000071066
650    12
$a presbyopie $x diagnóza $7 D011305
650    _2
$a psychometrie $7 D011594
650    _2
$a reprodukovatelnost výsledků $7 D015203
651    _2
$a Austrálie $7 D001315
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sloesen, Brigitte $u Novartis Pharma AG, Basel, Switzerland
700    1_
$a Bentley, Sarah $u Adelphi Values, Patient-Centered Outcomes, Bollington, UK
700    1_
$a Naujoks, Christel $u Novartis Pharma AG, Basel, Switzerland
700    1_
$a Arbuckle, Rob $u Adelphi Values, Patient-Centered Outcomes, Bollington, UK
700    1_
$a Chiva-Razavi, Sima $u Novartis Pharma AG, Basel, Switzerland
700    1_
$a Pascoe, Ben $u Adelphi Values, Patient-Centered Outcomes, Bollington, UK
700    1_
$a Stochl, Jan $u Adelphi Values, Patient-Centered Outcomes, Bollington, UK $u Charles University, Prague, Czechia
700    1_
$a Findley, Amy $u Adelphi Values, Patient-Centered Outcomes, Bollington, UK
700    1_
$a O'Brien, Paul $u Novartis Pharma AG, Basel, Switzerland
700    1_
$a Wolffsohn, James S $u School of Optometry, College of Health and Life Sciences, Aston University, Birmingham, UK
773    0_
$w MED00215150 $t Journal of patient-reported outcomes $x 2509-8020 $g Roč. 8, č. 1 (2024), s. 41
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38592339 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134417 $b ABA008
999    __
$a ok $b bmc $g 2143867 $s 1226213
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 8 $c 1 $d 41 $e 20240409 $i 2509-8020 $m Journal of patient-reported outcomes $n J Patient Rep Outcomes $x MED00215150
GRA    __
$a Novartis Pharma $p Novartis Pharma
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...